By Ryan Davis ( July 12, 2019, 9:47 PM EDT) -- The Federal Circuit ruled Friday that generic versions of the opioid addiction treatment Suboxone marketed by Dr. Reddy's and Alvogen do not infringe patents held by Indivior, but that a Teva unit's planned generic does infringe....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.